In a crowded oncology market, strategy-led storytelling, analytics-driven design, and sustainability-centered innovation are ...

ASCO® 2025 wasn’t only about oncology breakthroughs - it was also a showcase for how technology is redefining congress ...

This year’s ASCO® meeting spotlighted a bold shift in oncology: the possibility of curing metastatic disease. A new trial ...

Botanical drugs are stepping into the space between traditional remedies and modern pharmaceuticals. These are not ...

Sanofi’s investigational multiple myeloma (MM) therapy has been granted orphan drug designation by the US Food and Drug ...

With the changes at NHS England and the publishing of the 10-Year Plan, there is a lot of talk of change in the NHS in ...

Johnson & Johnson (J&J) has announced that it is seeking US Food and Drug Administration (FDA) approval to include new ...